Overview

Rebamipide (Regular & Nanoparticulated) vs. Clobetasol in Management of Methotrexate-Induced Oral Ulceration in Rheumatoid Arthritis Patients

Status:
Not yet recruiting

Trial end date:
2021-11-30

Target enrollment:

Participant gender:

Summary

The aim of this intervention study is to compare the effect of topical Rebamipide (regular and nanoparticulated) to topical Clobetasol propionate in management of Methotrexate induced oral mucositis in patients with rheumatoid arthritis.

Phase:

Phase 3

Details

Lead Sponsor:

Cairo University

Treatments:

Clobetasol
Rebamipide